There is no official maximum dose of Suboxone. The FDA labeling does not include a recommended maximum daily dosage for buprenorphine/naloxone products. The number most people encounter, 24 mg per day, is not a cap. It simply reflects the upper limit of what was tested in the original clinical trials. In December 2024, the FDA clarified this directly, stating that higher daily dosages “have not been investigated in randomized clinical trials but may be appropriate for some patients.”
Where the 24 mg Number Comes From
When Suboxone was first approved, clinical trials evaluated doses up to 24 mg of buprenorphine per day. Because no trials tested higher amounts, the labeling included the statement that doses above 24 mg “have not been demonstrated to provide any clinical advantage.” Over time, many prescribers and pharmacies interpreted this as a hard ceiling. It wasn’t. The FDA has since clarified that this language only described the limits of the available research, not the limits of the medication’s usefulness. A dose above 24 mg was never shown to be ineffective. It simply hadn’t been formally studied.
The recommended target dose listed on the label is 16 mg per day. This is where most patients stabilize during maintenance treatment, but it’s a target, not a boundary. Prescribers can and do adjust above this based on individual need.
What Prescribers Actually Use
In practice, most maintenance doses fall between 8 mg and 24 mg per day. Some patients do well at 16 mg, while others need the full 24 mg to manage cravings and withdrawal. A smaller number of patients, particularly those transitioning off high-potency synthetic opioids like fentanyl, may be prescribed 32 mg per day or even higher during induction. Emergency departments have begun using doses between 12 and 32 mg for opioid withdrawal, especially when standard protocols aren’t enough to stabilize someone coming off fentanyl.
Suboxone sublingual films come in two strengths: 2 mg/0.5 mg and 8 mg/2 mg (buprenorphine/naloxone). A 24 mg daily dose means taking three of the 8 mg films. A 32 mg dose means four. Higher doses require combining multiple films or strips throughout the day.
Why Higher Doses Help Some People
Buprenorphine works by attaching to the same brain receptors that opioids like heroin and fentanyl target. The more receptors it covers, the less room there is for other opioids to produce a high, and the less intense withdrawal symptoms become. Brain imaging research from a study published in Neuropsychopharmacology showed that a 16 mg dose blocks about 80% of these receptors, while 32 mg blocks roughly 84%. That extra 4% may sound small, but for someone with heavy fentanyl exposure, even a slight increase in receptor coverage can make a meaningful difference in controlling cravings and preventing relapse.
At low doses, the difference is dramatic. A 2 mg dose only blocks about 41% of receptors, which explains why it’s used mainly during the early stages of induction rather than for ongoing maintenance.
The Ceiling Effect and Safety
Buprenorphine is a partial opioid agonist, meaning it activates opioid receptors but only to a point. Unlike full opioids such as oxycodone or fentanyl, its effects on breathing level off as the dose increases. This is called the ceiling effect, and it’s the main reason buprenorphine is considered safer than other opioids at higher doses. The risk of fatal respiratory depression from buprenorphine alone is significantly lower than with full opioid agonists.
That said, “lower risk” is not “no risk.” Buprenorphine combined with benzodiazepines (anti-anxiety medications like diazepam or alprazolam) can cause life-threatening breathing problems. Deaths linked to buprenorphine almost always involve other sedating substances taken at the same time. This is the primary safety concern with any dose, not just high ones.
Side Effects at Higher Doses
Common side effects at any dose include headache, constipation, insomnia, dizziness, drowsiness, and sweating. These don’t necessarily worsen in a linear way as the dose goes up, but higher doses can increase drowsiness and fatigue.
Liver function is worth monitoring, especially at higher doses. Buprenorphine is generally well tolerated at standard sublingual doses, but some patients develop elevated liver enzymes. Most documented cases of significant liver injury involved patients who already had hepatitis C or other pre-existing liver conditions. The theory is that buprenorphine may stress liver cells that are already compromised by another condition. For patients without liver disease, the risk appears low, but periodic blood work is standard practice during treatment.
Why Your Dose Might Differ From Someone Else’s
The right Suboxone dose varies widely from person to person. It depends on what opioid you were using before treatment, how much of it, how long you used it, your body weight, your metabolism, and how you respond during the first days of induction. Someone transitioning off a moderate prescription painkiller habit may stabilize at 8 mg. Someone with years of fentanyl use might need 24 mg or more just to avoid withdrawal symptoms. Neither dose is wrong. The goal is the lowest dose that keeps you stable, prevents cravings, and lets you function normally, and for some people that number is higher than what older guidelines suggested.